These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

170 related items for PubMed ID: 4228698

  • 1. Immunoelectrophoretic characterization of plasma fibrinogen derivatives in patients with pathological plasma proteolysis.
    Fisher S, Fletcher AP, Alkjaersig N, Sherry S.
    J Lab Clin Med; 1967 Dec; 70(6):903-22. PubMed ID: 4228698
    [No Abstract] [Full Text] [Related]

  • 2. The importance of intermediate degradation products of fibrinogen in fibrinolytic hemorrhage.
    Marder VJ, Shulman NR, Carroll WR.
    Trans Assoc Am Physicians; 1967 Dec; 80():156-67. PubMed ID: 4230117
    [No Abstract] [Full Text] [Related]

  • 3. [Technics for the study of the blood coagulation and fibrinolytic system].
    Lasch HG, Heene D.
    Internist (Berl); 1968 Feb; 9(2):42-8. PubMed ID: 4234941
    [No Abstract] [Full Text] [Related]

  • 4. [Coagulation disorders after reinjection of concentrated ascitic fluid. Preliminary study].
    Buffet C, Conard J, Boulle J, Samama M, Levy VG.
    Med Chir Dig; 1973 Feb; 2(5):275-80. PubMed ID: 4275793
    [No Abstract] [Full Text] [Related]

  • 5. [Diagnosis and treatment of intravascular coagulation processes].
    Moriau M, Masure R.
    Nouv Rev Fr Hematol; 1968 Feb; 8(1):5-19. PubMed ID: 4232151
    [No Abstract] [Full Text] [Related]

  • 6. Properties of fibrinogenolysis and fibrinolysis products in immune assays.
    Beller FK, Maki M.
    Thromb Diath Haemorrh; 1967 Aug 15; 18(1-2):114-32. PubMed ID: 4229208
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Substrate composition and the effect of epsilon-aminocaproic acid on tissue plasminogen activator and urokinase-induced fibrinolysis.
    Thorsen S, Astrup T.
    Thromb Diath Haemorrh; 1974 Dec 31; 32(2-3):306-24. PubMed ID: 4281113
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Detection of hypercoagulable states with protamine sulphate tests.
    Lipinski B.
    Acta Univ Carol Med Monogr; 1972 Dec 31; 52():185-8. PubMed ID: 4273929
    [No Abstract] [Full Text] [Related]

  • 14. Measurement of fibrinogen and fibrin degradation products in serum by staphylococcal clumping test.
    Hawiger J, Niewiarowski S, Gurewich V, Thomas DP.
    J Lab Clin Med; 1970 Jan 31; 75(1):93-108. PubMed ID: 4243578
    [No Abstract] [Full Text] [Related]

  • 15. [Antifibrinolytic agents and extracorporeal circulation].
    Gomes OM, Freitas Neto AG, Wolosker M, Langer B, Dubieu WK, Zerbini EJ.
    Rev Hosp Clin Fac Med Sao Paulo; 1972 Jan 31; 27(5):209-13. PubMed ID: 4538812
    [No Abstract] [Full Text] [Related]

  • 16. [Studies on fibrinolysis in equivalents of the Sanarelli-Shwartzman phenomenon in obstetrics. Immunochemical demonstration of derivatives of fibrin(ogen)].
    Steichele DF, Herschlein HJ.
    Thromb Diath Haemorrh; 1967 Dec 31; 18(3-4):462-74. PubMed ID: 5590239
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Pharmacological enhancement and short-term stimulation of blood fibrinolytic activity.
    Laursen B, Gormsen J.
    Scand J Haematol; 1969 Dec 31; 6(6):402-8. PubMed ID: 5374117
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Effects on the human fibrinolytic system of prolonged intravenous infusion of high doses of Complamin (xantinol nicotinate).
    Bouvier CA, Berthoud S.
    Helv Med Acta; 1968 Mar 31; 34(2):170-86. PubMed ID: 4232105
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.